Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 50, Issue 3, 2014, Pages 583-594

  Venkatesan, Narayanan ^a   Tsuchiya, Kimitake ^a   Kolb, Martin ^b   Farkas, Laszlo ^b   Bourhim, Mustapha ^c   Ouzzine, Mohamed ^c   Ludwig, Mara S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Bleomycin; Fibroblasts; Glycosaminoglycans; Proteoglycans

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; BETA 1,3 GLUCURONOSYLTRANSFERASE I; BLEOMYCIN; CHONDROITIN 4 SULFOTRANSFERASE; CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; GLYCOSYLTRANSFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; SODIUM CHLORIDE; TRANSFERASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VERSICAN; XYLOSYLTRANSFERASE I;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LUNG FIBROBLAST; LUNG FIBROSIS; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; SULFATION; UPREGULATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; BLEOMYCIN; CELLS, CULTURED; CHONDROITIN SULFATES; DISEASE MODELS, ANIMAL; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONOSYLTRANSFERASE; GLYCOSAMINOGLYCANS; GLYCOSYLTRANSFERASES; LUNG; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PENTOSYLTRANSFERASES; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; SULFOTRANSFERASES; TIME FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; VERSICANS;

EID: 84895517059     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0226OC     Document Type: Article

References (60)

1. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011;208:1339-1350.
2. Keane MP, Strieter RM, Belperio JA. Mechanisms and mediators of pulmonary fibrosis. Crit Rev Immunol 2005;25:429-463.
3. Wilson MS, Wynn TA. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2009;2:103-121.
4. Lukacs NW, Hogaboam C, Chensue SW, Blease K, Kunkel SL. Type 1/type 2 cytokine paradigm and the progression of pulmonary fibrosis. Chest 2001;120(Suppl 1):5S-8S.
5. Phan SH. The myofibroblast in pulmonary fibrosis. Chest 2002;122 (Suppl 6):286S-289S.
6. Bensadoun ES, Burke AK, Hogg JC, Roberts CR. Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 1996; 154:1819-1828.
7. Roberts CR, Wight TN, Hascall VC. Proteoglycans. In: Crystal R, West J, Weibel E, Barnes P, editors. The lung: scientific foundations. Philadelphia: Lippincott-Raven Press; 1997. pp. 757-767.
8. Westergren-Thorsson G, Hernnäs J, Särnstrand B, Oldberg A, Heinegård D, Malmström A. Altered expression of small proteoglycans, collagen, and transforming growth factor-β 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest 1993;92:632-637.
9. Venkatesan N, Ebihara T, Roughley PJ, Ludwig MS. Alterations in large and small proteoglycans in bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med 2000;161:2066-2073.
10. Ebihara T, Venkatesan N, Tanaka R, Ludwig MS. Changes in extracellular matrix and tissue viscoelasticity in bleomycin-induced lung fibrosis: temporal aspects. Am J Respir Crit Care Med 2000; 162:1569-1576.
11. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998;67:609-652.
12. Cavalcante FS, Ito S, Brewer KK, Sakai H, Alencar AM, Almeida MP, Andrade JS Jr, Majumdar A, Ingenito EP, Suki B. Mechanical interactions between collagen and proteoglycans: implications for the stability of lung tissue. J Appl Physiol 2005;98:672-679.
13. Frevert CW, Sannes PL. Matrix proteoglycans as effector molecules for epithelial cell function. Eur Respir Rev 2005;14:137-144.
14. Venkatesan N, Roughley PJ, Ludwig MS. Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-β(1) and interferon-γ. Am J Physiol Lung Cell Mol Physiol 2002;283: L806-L814.
15. Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 2006;20:9-22.
16. Souza-Fernandes AB, Pelosi P, Rocco PRM. Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease. Crit Care 2006;10:237-252.
17. Sugahara K, Kitagawa H. Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr Opin Struct Biol 2000;10:518-527.
18. Sugahara K, Mikami T, Uyama T, Mizuguchi S, Nomura K, Kitagawa H. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr Opin Struct Biol 2003;13:612-620.
19. Mizuguchi S, Uyama T, Kitagawa H, Nomura KH, Dejima K, Gengyo-Ando K, Mitani S, Sugahara K, Nomura K. Chondroitin proteoglycans are involved in cell division of Caenorhabditis elegans. Nature 2003; 423:443-448.
20. Hwang HY, Olson SK, Esko JD, Horvitz HR. Caenorhabditis elegans early embryogenesis and vulval morphogenesis require chondroitin biosynthesis. Nature 2003;423:439-443.
21. Handel TM, Johnson Z, Crown SE, Lau EK, Proudfoot AE. Regulation of protein function by glycosaminoglycans - as exemplified by chemokines. Annu Rev Biochem 2005;74:385-410.
22. Salanga CL, Handel TM. Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp Cell Res 2011;317:590-601.
23. Prydz K, Dalen KT. Synthesis and sorting of proteoglycans. J Cell Sci 2000;113:193-205.
24. Venkatesan N, Ouzzine M, Kolb MR, Netter P, Ludwig MS. Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2011;300:L191-L203.
25. Laremore TN, Zhang F, Dordick JS, Liu J, Linhardt RJ. Recent progress and applications in glycosaminoglycan and heparin research. Curr Opin Chem Biol 2009;13:633-640.
26. Götting C, Kuhn J, Zahn R, Brinkmann T, Kleesiek K. Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J Mol Biol 2000; 304:517-528.
27. Almeida R, Levery SB, Mandel U, Kresse H, Schwientek T, Bennett EP, Clausen H. Cloning and expression of a proteoglycan UDPgalactose: β-xylose β1,4-galactosyltransferase I: a seventh member of the human β4-galactosyltransferase gene family. J Biol Chem 1999;274:26165-26171.
28. Okajima T, Yoshida K, Kondo T, Furukawa K. Human homolog of Caenorhabditis elegans sqv-3 gene is galactosyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J Biol Chem 1999;274: 22915-22918.
29. Bai X, Zhou D, Brown JR, Crawford BE, Hennet T, Esko JD. Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the β 1,3- galactosyltransferase family (β 3GalT6). J Biol Chem 2001;276: 48189-48195.
30. Kitagawa H, Tone Y, Tamura J, Neumann KW, Ogawa T, Oka S, Kawasaki T, Sugahara K. Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J Biol Chem 1998;273:6615-6618.
31. Wei G, Bai X, Sarkar AK, Esko JD. Formation of HNK-1 determinants and the glycosaminoglycan tetrasaccharide linkage region by UDP-GlcUA: Galactose β1, 3-glucuronosyltransferases. J Biol Chem 1999; 274:7857-7864.
32. Venkatesan N, Barré L, Magdalou J, Mainard D, Netter P, Fournel-Gigleux S, Ouzzine M. Modulation of xylosyltransferase I expression provides a mechanism regulating glycosaminoglycan chain synthesis during cartilage destruction and repair. FASEB J 2009;23: 813-822.
33. Venkatesan N, Barré L, Bourhim M, Magdalou J, Mainard D, Netter P, Fournel-Gigleux S, Ouzzine M. Xylosyltransferase-I regulates glycosaminoglycan synthesis during the pathogenic process of human osteoarthritis. PLoS ONE 2012;7:e34020.
34. Venkatesan N, Barré L, Benani A, Netter P, Magdalou J, Fournel-Gigleux S, Ouzzine M. Stimulation of proteoglycan synthesis by glucuronosyltransferase-I gene delivery: a strategy to promote cartilage repair. Proc Natl Acad Sci USA 2004;101: 18087-18092.
35. Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002; 62:65-74.
36. Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, Martin W, Fornwald J, Lehr R, Harling J, et al. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 2002;62:58-64.
37. English JM, Cobb MH. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 2002;23:40-45.
38. Clark JG, Kostal KM, Marino BA. Modulation of collagen production following bleomycin-induced pulmonary fibrosis in hamsters: presence of a factor in lung that increases fibroblast prostaglandin E2 and cAMP and suppresses fibroblast proliferation and collagen production. J Biol Chem 1982;257:8098-8105.
39. Salazar KD, Lankford SM, Brody AR. Mesenchymal stem cells produce Wnt isoforms and TGF-β1 that mediate proliferation and procollagen expression by lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2009;297:L1002-L1011.
40. Sakko AJ, Ricciardelli C, Mayne K, Tilley WD, Lebaron RG, Horsfall DJ. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1. Cancer Res 2001;61:926-930.
41. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovectormediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997;100: 768-776.
42. Farkas L, Farkas D, Ask K, Möller A, Gauldie J, Margetts P, Inman M, Kolb M. VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. J Clin Invest 2009;119:1298-1311.
43. Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 2007;257:143-179.
44. Kisseleva T, Brenner DA. Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 2008;233:109-122.
45. Phan SH, Varani J, Smith D. Rat lung fibroblast collagen metabolism in bleomycin-induced pulmonary fibrosis. J Clin Invest 1985;76: 241-247.
46. Raghu G, Masta S, Meyers D, Narayanan AS. Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-b. Am Rev Respir Dis 1989;140:95-100.
47. Ungefroren H, Groth S, Ruhnke M, Kalthoff H, Fändrich F. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta. J Biol Chem 2005;280:2644-2652.
48. Crouch E. Pathobiology of pulmonary fibrosis. Am J Physiol 1990;259: L159-L184.
49. Massagué J, Chen YG. Controlling TGF-β signaling. Genes Dev 2000; 14:627-644.
50. Massagué J. How cells read TGF-β signals. Nat Rev Mol Cell Biol 2000; 1:169-178.
51. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation of the TGF-β receptor. Nature 1994;370:341-347.
52. Moustakas A, Heldin CH. The regulation of TGFbeta signal transduction. Development 2009;136:3699-3714.
53. Prante C, Milting H, Kassner A, Farr M, Ambrosius M, Schön S, Seidler DG, Banayosy AE, Körfer R, Kuhn J, et al. Transforming growth factor β1-regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling. J Biol Chem 2007;282:26441-26449.
54. Matsuoka H, Arai T, Mori M, Goya S, Kida H, Morishita H, Fujiwara H, Tachibana I, Osaki T, Hayashi S. A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2002;283:L103-L112.
55. Venkatesan N, Pini L, Ludwig MS. Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2004;287:L1342-L1347.
56. Gonzalez AV, Le Bellego F, Ludwig MS. Imbalance of receptor-regulated and inhibitory Smads in lung fibroblasts from bleomycin-exposed rats. Am J Respir Cell Mol Biol 2007;36:206-212.
57. Lali FV, Hunt AE, Turner SJ, Foxwell BM. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J Biol Chem 2000;275:7395-7402.
58. Kuang PP, Zhang XH, Rich CB, Foster JA, Subramanian M, Goldstein RH. Activation of elastin transcription by transforming growth factorbeta in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2007;292:L944-L952.
59. Garćia-Alvarez J, Ramirez R, Checa M, Nuttall RK, Sampieri CL, Edwards DR, Selman M, Pardo A. Tissue inhibitor of metalloproteinase-3 is up-regulated by transforming growth factorbeta1 in vitro and expressed in fibroblastic foci in vivo in idiopathic pulmonary fibrosis. Exp Lung Res 2006;32:201-214.
60. Dadlani H, Ballinger ML, Osman N, Getachew R, Little PJ. Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle. J Biol Chem 2008;283:7844-7852.